174 related articles for article (PubMed ID: 29720484)
21. Radotinib inhibits acute myeloid leukemia cell proliferation via induction of mitochondrial-dependent apoptosis and CDK inhibitors.
Heo SK; Noh EK; Gwon GD; Kim JY; Jo JC; Choi Y; Koh S; Baek JH; Min YJ; Kim H
Eur J Pharmacol; 2016 Oct; 789():280-290. PubMed ID: 27477352
[TBL] [Abstract][Full Text] [Related]
22. Securinine, a myeloid differentiation agent with therapeutic potential for AML.
Gupta K; Chakrabarti A; Rana S; Ramdeo R; Roth BL; Agarwal ML; Tse W; Agarwal MK; Wald DN
PLoS One; 2011; 6(6):e21203. PubMed ID: 21731671
[TBL] [Abstract][Full Text] [Related]
23. E6AP inhibits G-CSFR turnover and functions by promoting its ubiquitin-dependent proteasome degradation.
Chhabra S; Kumar Y; Thacker G; Kapoor I; Lochab S; Sanyal S; Bhatt MLB; Chattopadhyay N; Trivedi AK
Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1545-1553. PubMed ID: 28578910
[TBL] [Abstract][Full Text] [Related]
24. l-Asparaginase-mediated downregulation of c-Myc promotes 1,25(OH)
Song JH; Park E; Kim MS; Cho KM; Park SH; Lee A; Song J; Kim HJ; Koh JT; Kim TS
Int J Cancer; 2017 May; 140(10):2364-2374. PubMed ID: 28224619
[TBL] [Abstract][Full Text] [Related]
25. A Novel Glycogen Synthase Kinase-3 Inhibitor Optimized for Acute Myeloid Leukemia Differentiation Activity.
Hu S; Ueda M; Stetson L; Ignatz-Hoover J; Moreton S; Chakrabarti A; Xia Z; Karan G; de Lima M; Agrawal MK; Wald DN
Mol Cancer Ther; 2016 Jul; 15(7):1485-1494. PubMed ID: 27196775
[TBL] [Abstract][Full Text] [Related]
26. Complex regulation of CDKs and G1 arrest during the granulocytic differentiation of human myeloblastic leukemia ML-1 cells.
Shimizu T; Awai N; Takeda K
Oncogene; 2000 Sep; 19(40):4640-6. PubMed ID: 11030153
[TBL] [Abstract][Full Text] [Related]
27. Changes in glycosphingolipid composition during differentiation of human leukemic granulocytes in chronic myelogenous leukemia compared with in vitro granulocytic differentiation of human promyelocytic leukemia cell line HL-60.
Nojiri H; Takaku F; Ohta M; Miura Y; Saito M
Cancer Res; 1985 Dec; 45(12 Pt 1):6100-6. PubMed ID: 3864527
[TBL] [Abstract][Full Text] [Related]
28. Inhibitor of cyclin-dependent kinase (CDK) interacting with cyclin A1 (INCA1) regulates proliferation and is repressed by oncogenic signaling.
Bäumer N; Tickenbrock L; Tschanter P; Lohmeyer L; Diederichs S; Bäumer S; Skryabin BV; Zhang F; Agrawal-Singh S; Köhler G; Berdel WE; Serve H; Koschmieder S; Müller-Tidow C
J Biol Chem; 2011 Aug; 286(32):28210-22. PubMed ID: 21540187
[TBL] [Abstract][Full Text] [Related]
29. CUEDC2, a novel interacting partner of the SOCS1 protein, plays important roles in the leukaemogenesis of acute myeloid leukaemia.
Wu QY; Zhu YY; Liu Y; Wei F; Tong YX; Cao J; Zhou P; Niu MS; Li ZY; Zeng LY; Li F; Xu KL
Cell Death Dis; 2018 Jul; 9(7):774. PubMed ID: 29991678
[TBL] [Abstract][Full Text] [Related]
30. Noncatalytic requirement for cyclin A-cdk2 in p27 turnover.
Zhu XH; Nguyen H; Halicka HD; Traganos F; Koff A
Mol Cell Biol; 2004 Jul; 24(13):6058-66. PubMed ID: 15199159
[TBL] [Abstract][Full Text] [Related]
31. Activation of orphan receptor GPR132 induces cell differentiation in acute myeloid leukemia.
Yi C; He J; Huang D; Zhao Y; Zhang C; Ye X; Huang Y; Nussinov R; Zheng J; Liu M; Lu W
Cell Death Dis; 2022 Nov; 13(11):1004. PubMed ID: 36437247
[TBL] [Abstract][Full Text] [Related]
32. Dual Inhibition of CDK4 and CDK2 via Targeting p27 Tyrosine Phosphorylation Induces a Potent and Durable Response in Breast Cancer Cells.
Patel P; Tsiperson V; Gottesman SRS; Somma J; Blain SW
Mol Cancer Res; 2018 Mar; 16(3):361-377. PubMed ID: 29330290
[TBL] [Abstract][Full Text] [Related]
33. Cell cycle regulatory protein expression in fresh acute myeloid leukemia cells and after drug exposure.
Radosevic N; Delmer A; Tang R; Marie JP; Ajchenbaum-Cymbalista F
Leukemia; 2001 Apr; 15(4):559-66. PubMed ID: 11368357
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide analysis of histone H3 acetylation patterns in AML identifies PRDX2 as an epigenetically silenced tumor suppressor gene.
Agrawal-Singh S; Isken F; Agelopoulos K; Klein HU; Thoennissen NH; Koehler G; Hascher A; Bäumer N; Berdel WE; Thiede C; Ehninger G; Becker A; Schlenke P; Wang Y; McClelland M; Krug U; Koschmieder S; Büchner T; Yu DY; Singh SV; Hansen K; Serve H; Dugas M; Müller-Tidow C
Blood; 2012 Mar; 119(10):2346-57. PubMed ID: 22207736
[TBL] [Abstract][Full Text] [Related]
35. Induction of autophagy is a key component of all-trans-retinoic acid-induced differentiation in leukemia cells and a potential target for pharmacologic modulation.
Orfali N; O'Donovan TR; Nyhan MJ; Britschgi A; Tschan MP; Cahill MR; Mongan NP; Gudas LJ; McKenna SL
Exp Hematol; 2015 Sep; 43(9):781-93.e2. PubMed ID: 25986473
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of Dihydroorotate Dehydrogenase Overcomes Differentiation Blockade in Acute Myeloid Leukemia.
Sykes DB; Kfoury YS; Mercier FE; Wawer MJ; Law JM; Haynes MK; Lewis TA; Schajnovitz A; Jain E; Lee D; Meyer H; Pierce KA; Tolliday NJ; Waller A; Ferrara SJ; Eheim AL; Stoeckigt D; Maxcy KL; Cobert JM; Bachand J; Szekely BA; Mukherjee S; Sklar LA; Kotz JD; Clish CB; Sadreyev RI; Clemons PA; Janzer A; Schreiber SL; Scadden DT
Cell; 2016 Sep; 167(1):171-186.e15. PubMed ID: 27641501
[TBL] [Abstract][Full Text] [Related]
37. Effect of AML serum on normal human myeloid differentiation and hexamethylene bisacetamide-induced granulocytic differentiation of the human HL-60 promyelocytic leukaemic cell line.
Hassan HT; Rees JK
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(1):151-9. PubMed ID: 1695170
[TBL] [Abstract][Full Text] [Related]
38. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
39. S100A9 induces differentiation of acute myeloid leukemia cells through TLR4.
Laouedj M; Tardif MR; Gil L; Raquil MA; Lachhab A; Pelletier M; Tessier PA; Barabé F
Blood; 2017 Apr; 129(14):1980-1990. PubMed ID: 28137827
[TBL] [Abstract][Full Text] [Related]
40. Monensin-mediated growth inhibition in acute myelogenous leukemia cells via cell cycle arrest and apoptosis.
Park WH; Lee MS; Park K; Kim ES; Kim BK; Lee YY
Int J Cancer; 2002 Sep; 101(3):235-42. PubMed ID: 12209973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
